![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | SP3 | Human | (+)-catechin | multiple interactions | EXP | | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of SP3 mRNA | CTD | PMID:24763279 | SP3 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Sp3 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of SP3 mRNA | CTD | PMID:22206623 | SP3 | Human | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | increases expression | ISO | Sp3 (Mus musculus) | 6480464 | 1-Methyl-4-phenyl-1 more ... | CTD | PMID:29071302 | SP3 | Human | 17alpha-ethynylestradiol | multiple interactions | ISO | Sp3 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SP3 mRNA | CTD | PMID:17942748 | SP3 | Human | 17beta-estradiol | affects expression | ISO | Sp3 (Rattus norvegicus) | 6480464 | Estradiol affects the expression of SP3 mRNA | CTD | PMID:32145629 | SP3 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Sp3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SP3 mRNA | CTD | PMID:24058054 | SP3 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Sp3 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SP3 mRNA | CTD | PMID:32109520 | SP3 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Sp3 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SP3 mRNA | CTD | PMID:17942748 | SP3 | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of SP3 mRNA | CTD | PMID:21179406 | SP3 | Human | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol S co-treated with Fulvestrant] results in decreased methylation of SP3 gene | CTD | PMID:31601247 | SP3 | Human | 4,4'-sulfonyldiphenol | decreases methylation | EXP | | 6480464 | bisphenol S results in decreased methylation of SP3 gene | CTD | PMID:31601247 | SP3 | Human | 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | [Decitabine co-treated with trichostatin A] promotes the reaction [SP3 protein binds to CLDN3 promoter] more ... | CTD | PMID:17986852 and PMID:18033804 | SP3 | Human | 5-fluorouracil | multiple interactions | EXP | | 6480464 | TP53 protein affects the reaction [Fluorouracil results in decreased expression of SP3 mRNA] | CTD | PMID:15016801 | SP3 | Human | 7,12-dimethyltetraphene | increases expression | ISO | Sp3 (Rattus norvegicus) | 6480464 | 9 more ... | CTD | PMID:36863560 | SP3 | Human | aflatoxin B1 | increases expression | ISO | Sp3 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of SP3 mRNA | CTD | PMID:19770486 | SP3 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of SP3 gene | CTD | PMID:27153756 | SP3 | Human | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of SP3 mRNA | CTD | PMID:24449571 | SP3 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of SP3 mRNA and aristolochic acid I results in decreased expression of SP3 protein | CTD | PMID:33212167 | SP3 | Human | arsenous acid | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of SP3 mRNA and Arsenic Trioxide results in decreased expression of SP3 protein | CTD | PMID:20435036 | SP3 | Human | arsenous acid | decreases expression | ISO | Sp3 (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of SP3 mRNA | CTD | PMID:35676786 | SP3 | Human | benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of SP3 mRNA | CTD | PMID:21382456 | SP3 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of SP3 promoter | CTD | PMID:27901495 | SP3 | Human | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 | SP3 | Human | biotin | increases expression | ISO | Sp3 (Mus musculus) | 6480464 | Biotin results in increased expression of SP3 mRNA | CTD | PMID:34699867 | SP3 | Human | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of SP3 protein | CTD | PMID:25068794 | SP3 | Human | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Sp3 (Rattus norvegicus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of SP3 protein | CTD | PMID:25068794 | SP3 | Human | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Sp3 (Rattus norvegicus) | 6480464 | HDAC4 mutant form inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SP3 protein] | CTD | PMID:25068794 | SP3 | Human | bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SP3 protein] more ... | CTD | PMID:25068794 | SP3 | Human | bisphenol A | increases expression | ISO | Sp3 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of SP3 mRNA | CTD | PMID:30816183 and PMID:32145629 | SP3 | Human | bisphenol A | increases expression | ISO | Sp3 (Mus musculus) | 6480464 | bisphenol A results in increased expression of SP3 mRNA | CTD | PMID:37894381 | SP3 | Human | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of SP3 gene | CTD | PMID:31601247 | SP3 | Human | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SP3 mRNA | CTD | PMID:35301059 | SP3 | Human | cadmium dichloride | multiple interactions | ISO | Sp3 (Mus musculus) | 6480464 | Cadmium Chloride inhibits the reaction [SP1 protein binds to SP3 protein binds to KLF4 protein binds to E2F1 protein binds to NECTIN2 promoter] | CTD | PMID:25046863 | SP3 | Human | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SP3 mRNA | CTD | PMID:35301059 | SP3 | Human | caffeine | increases phosphorylation | EXP | | 6480464 | Caffeine results in increased phosphorylation of SP3 protein | CTD | PMID:35688186 | SP3 | Human | camptothecin | increases activity | EXP | | 6480464 | Camptothecin results in increased activity of SP3 protein | CTD | PMID:11261509 | SP3 | Human | camptothecin | multiple interactions | EXP | | 6480464 | mithramycin A inhibits the reaction [Camptothecin results in increased activity of SP3 protein] | CTD | PMID:11261509 | SP3 | Human | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of SP3 mRNA | CTD | PMID:25979313 | SP3 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SP3 gene] | CTD | PMID:28238834 | SP3 | Human | chlorpyrifos | decreases expression | ISO | Sp3 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of SP3 mRNA | CTD | PMID:37019170 | SP3 | Human | copper atom | affects expression | EXP | | 6480464 | Copper affects the expression of SP3 protein | CTD | PMID:22172574 | SP3 | Human | copper(0) | affects expression | EXP | | 6480464 | Copper affects the expression of SP3 protein | CTD | PMID:22172574 | SP3 | Human | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of SP3 | CTD | PMID:22172574 | SP3 | Human | cordycepin | increases activity | EXP | | 6480464 | cordycepin results in increased activity of SP3 protein | CTD | PMID:19051361 | SP3 | Human | coumarin | increases phosphorylation | EXP | | 6480464 | coumarin results in increased phosphorylation of SP3 protein | CTD | PMID:35688186 | SP3 | Human | crocidolite asbestos | decreases expression | ISO | Sp3 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of SP3 mRNA | CTD | PMID:29279043 | SP3 | Human | curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of SP3 protein | CTD | PMID:18593936 | SP3 | Human | daunorubicin | increases expression | EXP | | 6480464 | Daunorubicin results in increased expression of SP3 protein | CTD | PMID:19698806 | SP3 | Human | decabromodiphenyl ether | increases expression | ISO | Sp3 (Rattus norvegicus) | 6480464 | decabromobiphenyl ether results in increased expression of SP3 mRNA | CTD | PMID:23914054 | SP3 | Human | diarsenic trioxide | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of SP3 mRNA and Arsenic Trioxide results in decreased expression of SP3 protein | CTD | PMID:20435036 | SP3 | Human | diarsenic trioxide | decreases expression | ISO | Sp3 (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of SP3 mRNA | CTD | PMID:35676786 | SP3 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of SP3 mRNA | CTD | PMID:37042841 | SP3 | Human | dichloromethane | increases expression | ISO | Sp3 (Mus musculus) | 6480464 | Methylene Chloride results in increased expression of SP3 mRNA | CTD | PMID:28392392 | SP3 | Human | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of SP3 mRNA | CTD | PMID:28302478 | SP3 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SP3 mRNA | CTD | PMID:27188386 | SP3 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of SP3 mRNA | CTD | PMID:29803840 | SP3 | Human | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SP3 protein | CTD | PMID:23301498 | SP3 | Human | fenvalerate | increases expression | ISO | Sp3 (Rattus norvegicus) | 6480464 | fenvalerate results in increased expression of SP3 mRNA | CTD | PMID:30307764 | SP3 | Human | fluoranthene | multiple interactions | ISO | Sp3 (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of SP3 mRNA | CTD | PMID:28329830 | SP3 | Human | folic acid | decreases expression | ISO | Sp3 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of SP3 mRNA | CTD | PMID:25629700 | SP3 | Human | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of SP3 protein | CTD | PMID:37730182 | SP3 | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol S co-treated with Fulvestrant] results in decreased methylation of SP3 gene and Fulvestrant promotes the reaction [SP3 protein binds to ESRRA promoter] | CTD | PMID:20211987 and PMID:31601247 | SP3 | Human | gentamycin | decreases expression | ISO | Sp3 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of SP3 mRNA | CTD | PMID:22061828 | SP3 | Human | glutathione | multiple interactions | EXP | | 6480464 | Glutathione inhibits the reaction [Hydrogen Peroxide results in decreased expression of SP3 protein] | CTD | PMID:20435036 | SP3 | Human | gold atom | decreases expression | EXP | | 6480464 | Gold results in decreased expression of SP3 mRNA | CTD | PMID:25523186 | SP3 | Human | gold(0) | decreases expression | EXP | | 6480464 | Gold results in decreased expression of SP3 mRNA | CTD | PMID:25523186 | SP3 | Human | homocysteic acid | multiple interactions | EXP | | 6480464 | mithramycin A inhibits the reaction [homocysteic acid results in increased activity of SP3 protein] | CTD | PMID:11261509 | SP3 | Human | homocysteic acid | increases activity | EXP | | 6480464 | homocysteic acid results in increased activity of SP3 protein | CTD | PMID:11261509 | SP3 | Human | hydrogen peroxide | multiple interactions | EXP | | 6480464 | Glutathione inhibits the reaction [Hydrogen Peroxide results in decreased expression of SP3 protein] | CTD | PMID:20435036 | SP3 | Human | hydrogen peroxide | decreases expression | EXP | | 6480464 | Hydrogen Peroxide results in decreased expression of SP3 protein | CTD | PMID:20435036 | SP3 | Human | L-ascorbic acid | decreases expression | EXP | | 6480464 | Ascorbic Acid results in decreased expression of SP3 protein | CTD | PMID:21919647 | SP3 | Human | lead nitrate | multiple interactions | ISO | Sp3 (Mus musculus) | 6480464 | lead nitrate affects the reaction [SP3 affects the expression of MT1 mRNA] and lead nitrate affects the reaction [SP3 affects the expression of MT2 mRNA] | CTD | PMID:11891201 | SP3 | Human | lead nitrate | decreases expression | ISO | Sp3 (Mus musculus) | 6480464 | lead nitrate results in decreased expression of SP3 mRNA | CTD | PMID:11891201 | SP3 | Human | lead(0) | increases expression | EXP | | 6480464 | Lead results in increased expression of SP3 protein | CTD | PMID:22272629 | SP3 | Human | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of SP3 mRNA | CTD | PMID:28988120 | SP3 | Human | MC1568 | multiple interactions | EXP | | 6480464 | MC1568 inhibits the reaction [Diethylhexyl Phthalate inhibits the reaction [SP3 protein binds to NGB promoter]] more ... | CTD | PMID:25068794 | SP3 | Human | MC1568 | increases expression | EXP | | 6480464 | MC1568 results in increased expression of SP3 protein | CTD | PMID:25068794 | SP3 | Human | metformin | decreases expression | EXP | | 6480464 | Metformin results in decreased expression of SP3 protein | CTD | PMID:26317792 | SP3 | Human | methotrexate | affects expression | ISO | Sp3 (Mus musculus) | 6480464 | Methotrexate affects the expression of SP3 mRNA | CTD | PMID:18502557 | SP3 | Human | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of SP3 mRNA | CTD | PMID:28001369 | SP3 | Human | N,N-diethyl-m-toluamide | multiple interactions | ISO | Sp3 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of SP3 gene | CTD | PMID:33148267 | SP3 | Human | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SP3 protein] | CTD | PMID:25068794 | SP3 | Human | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SP3 protein | CTD | PMID:25068794 | SP3 | Human | nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of SP3 mRNA | CTD | PMID:18651567 | SP3 | Human | nitrates | multiple interactions | ISO | Sp3 (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SP3 mRNA | CTD | PMID:35964746 | SP3 | Human | paraquat | affects expression | ISO | Sp3 (Mus musculus) | 6480464 | Paraquat affects the expression of SP3 mRNA and Paraquat affects the expression of SP3 protein | CTD | PMID:31368498 | SP3 | Human | perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of SP3 mRNA | CTD | PMID:27153767 | SP3 | Human | permethrin | multiple interactions | ISO | Sp3 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of SP3 gene | CTD | PMID:33148267 | SP3 | Human | phenobarbital | increases expression | ISO | Sp3 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of SP3 mRNA | CTD | PMID:19270015 | SP3 | Human | phenobarbital | affects expression | ISO | Sp3 (Mus musculus) | 6480464 | Phenobarbital affects the expression of SP3 mRNA | CTD | PMID:23091169 | SP3 | Human | phenytoin | increases expression | EXP | | 6480464 | Phenytoin results in increased expression of SP3 mRNA | CTD | PMID:14741686 | SP3 | Human | pirinixic acid | increases expression | ISO | Sp3 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of SP3 mRNA | CTD | PMID:18301758 | SP3 | Human | potassium dichromate | increases expression | ISO | Sp3 (Mus musculus) | 6480464 | Potassium Dichromate results in increased expression of SP3 mRNA | CTD | PMID:23608068 | SP3 | Human | promegestone | multiple interactions | EXP | | 6480464 | mithramycin A inhibits the reaction [Promegestone promotes the reaction [SP3 protein binds to HSD17B2 promoter]] and Promegestone promotes the reaction [SP3 protein binds to HSD17B2 promoter] | CTD | PMID:16807381 | SP3 | Human | promegestone | increases expression | EXP | | 6480464 | Promegestone results in increased expression of SP3 mRNA and Promegestone results in increased expression of SP3 protein | CTD | PMID:16807381 | SP3 | Human | quercetin | multiple interactions | EXP | | 6480464 | [Quercetin co-treated with hyperoside] results in decreased expression of SP3 mRNA more ... | CTD | PMID:23530649 and PMID:24173369 | SP3 | Human | quercetin 3-O-beta-D-galactopyranoside | multiple interactions | EXP | | 6480464 | [Quercetin co-treated with hyperoside] results in decreased expression of SP3 mRNA and [Quercetin co-treated with hyperoside] results in decreased expression of SP3 protein | CTD | PMID:24173369 | SP3 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with Quercetin] results in decreased expression of SP3 mRNA and [resveratrol co-treated with Quercetin] results in decreased expression of SP3 protein | CTD | PMID:23530649 | SP3 | Human | S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | EXP | | 6480464 | mithramycin A inhibits the reaction [Buthionine Sulfoximine results in increased activity of SP3 protein] | CTD | PMID:11261509 | SP3 | Human | S-butyl-DL-homocysteine (S,R)-sulfoximine | increases activity | EXP | | 6480464 | Buthionine Sulfoximine results in increased activity of SP3 protein | CTD | PMID:11261509 | SP3 | Human | S-nitrosoglutathione | decreases activity | EXP | | 6480464 | S-Nitrosoglutathione results in decreased activity of SP3 protein | CTD | PMID:14766015 | SP3 | Human | S-nitrosoglutathione | increases activity | EXP | | 6480464 | S-Nitrosoglutathione results in increased activity of SP3 protein | CTD | PMID:14766015 | SP3 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:37664457 | SP3 | Human | Se-methyl-L-selenocysteine | multiple interactions | EXP | | 6480464 | selenomethylselenocysteine metabolite promotes the reaction [SP3 protein binds to BMF promoter] | CTD | PMID:25321483 | SP3 | Human | Se-methylselenocysteine | multiple interactions | EXP | | 6480464 | selenomethylselenocysteine metabolite promotes the reaction [SP3 protein binds to BMF promoter] | CTD | PMID:25321483 | SP3 | Human | silver atom | decreases expression | ISO | Sp3 (Mus musculus) | 6480464 | Silver results in decreased expression of SP3 mRNA | CTD | PMID:27131904 | SP3 | Human | silver(0) | decreases expression | ISO | Sp3 (Mus musculus) | 6480464 | Silver results in decreased expression of SP3 mRNA | CTD | PMID:27131904 | SP3 | Human | sodium arsenate | increases expression | ISO | Sp3 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of SP3 mRNA | CTD | PMID:21795629 | SP3 | Human | sodium arsenate | decreases expression | ISO | Sp3 (Mus musculus) | 6480464 | sodium arsenate results in decreased expression of SP3 mRNA | CTD | PMID:21795629 | SP3 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of SP3 mRNA | CTD | PMID:12016162 | SP3 | Human | tamoxifen | multiple interactions | EXP | | 6480464 | Tamoxifen promotes the reaction [SP3 protein binds to ESRRA promoter] | CTD | PMID:20211987 | SP3 | Human | tetrathiomolybdate(2-) | decreases expression | EXP | | 6480464 | tetrathiomolybdate results in decreased expression of SP3 | CTD | PMID:22172574 | SP3 | Human | titanium dioxide | decreases methylation | ISO | Sp3 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of SP3 gene and titanium dioxide results in decreased methylation of SP3 promoter | CTD | PMID:35295148 | SP3 | Human | trichostatin A | multiple interactions | EXP | | 6480464 | [Decitabine co-treated with trichostatin A] promotes the reaction [SP3 protein binds to CLDN3 promoter] more ... | CTD | PMID:17986852 and PMID:27188386 | SP3 | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of SP3 mRNA | CTD | PMID:24935251 and PMID:26272509 | SP3 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of SP3 mRNA | CTD | PMID:37042841 | SP3 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of SP3 mRNA | CTD | PMID:25979313 | SP3 | Human | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of SP3 gene | CTD | PMID:28853863 more ... | SP3 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of SP3 mRNA | CTD | PMID:23179753 more ... | SP3 | Human | vinclozolin | increases expression | ISO | Sp3 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of SP3 mRNA | CTD | PMID:23555832 | SP3 | Human | vorinostat | multiple interactions | EXP | | 6480464 | SP3 protein promotes the reaction [vorinostat results in increased expression of CDKN1A mRNA] | CTD | PMID:11126357 | |